Evaluation of Clinical, Perceived and Instrumental Efficacy of a Scar Gel in Preventing Hypertrophic Scars

ConditionsAcceptability Study Real-use Conditions Safety and Efficacy Topical Administration Hypertrophic Scars Keloid Scars

Trial statusRecruiting

Trial phasePhase 1, Phase 2

Trial typeInterventional

Biological sexAll

Age18-70

SponsorHerbarium Laboratorio Botanico Ltda

About this trial

Evaluation of the safety and topical efficacy of a scar gel after 90 days of continuous use, comparing it to a benchmark for preventing hypertrophic scars and improving appearance, hydration and pigmentation.

Eligibility criteria

Qualifiers

Participants of both sexes aged between 18 and 70 years;

Participants with recent scars (<30 days);

Participants with phototypes III to VI according to the Fitzpatrick scale;

Agree to follow the trial procedures and attend the center on the days and times determined for evaluations;

Disqualifiers

Pregnancy or risk of pregnancy;

History of atopic or allergic reactions to cosmetic products;

Participants who are using topical antibiotics or other skin products on the same area being evaluated;

Immunosuppression due to drugs or active diseases;

Trial design

Treatments tested in this trial

Scar gel
Scar gel comparator

Treatment groups

80 Participants

are divided into 2 treatment groups

Sponsors and collaborators

Herbarium Laboratorio Botanico Ltda

Lead sponsor

Source ClinicalTrials.gov